Papers: 10.1371/journal.pone.0248748

https://doi.org/10.1371/journal.pone.0248748

Cost-effectiveness of a “treat-all” strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages

Cited by: 2
Author(s): R Suenaga, Machi Suka, Tomohiro Hirao, Isao Hidaka, Isao Sakaida, Hideyuki Ishida
Published: over 5 years ago

Software Mentions 1